HELIOS Kliniken

DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer (2024) Borm KJ, Behzadi ST, Hörner-Rieber J, Krug D, Baumann R, Corradini S, Duma MN, et al. Journal article, Review article Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics (2024) Rius Rigau AR, Li YN, Matei AE, Györfi AH, Bruch PM, Koziel S, Devakumar V, et al. Journal article, Original article Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis (2024) Liang M, Dickel N, Györfi AH, SafakTümerdem B, Li YN, Rius Rigau AR, Liang C, et al. Journal article Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis (2024) Trinh-Minh T, Chen CW, Tran-Manh C, Li YN, Zhu H, Zhou X, Chakraborty D, et al. Journal article Ribociclib plus Endocrine Therapy in Early Breast Cancer (2024) Slamon D, Lipatov O, Nowecki Z, McAndrew N, Kukielka-Budny B, Stroyakovskiy D, Yardley DA, et al. Journal article Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program (2024) Wiesenfarth M, Dorst J, Brenner D, Elmas Z, Parlak Ö, Uzelac Z, Kandler K, et al. Journal article ABC7 Consensus: Assessment by a German Group of Experts (2024) Ditsch N, Untch M, Fasching P, Busch S, Ettl J, Haidinger R, Jackisch C, et al. Journal article Transoral laser microsurgery for supraglottic carcinomas: results of a prospective multicenter trial (SUPRATOL) (2024) Ambrosch P, Meuret S, Dietz A, Fazel A, Fietkau R, Tostmann R, Schroeder U, et al. Journal article Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort (2024) Tscharntke LT, Jung N, Hanses F, Koll CE, Pilgram L, Rieg S, Borgmann S, et al. Journal article Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens. (2024) Baden D, Zukunft S, Hernandez G, Wolgast N, Steinhauser S, Pohlmann A, Schliemann C, et al. Journal article